{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:54:20Z","timestamp":1792630460094,"version":"4.5.0"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The insulin-like growth factor (IGF) pathway comprises two activating ligands (IGF-I and IGF-II), two cell-surface receptors (IGF-IR and IGF-IIR), six IGF binding proteins (IGFBP) and nine IGFBP related proteins. IGF-I and the IGF-IR share substantial structural and functional similarities to those of insulin and its receptor. IGF-I plays important regulatory roles in the development, growth, and function of many human tissues. Its pathway intersects with those mediating the actions of many cytokines, growth factors and hormones. Among these, IGFs impact the thyroid and the hormones that it generates. Further, thyroid hormones and thyrotropin (TSH) can influence the biological effects of growth hormone and IGF-I on target tissues. The consequences of this two-way interplay can be far-reaching on many metabolic and immunologic processes. Specifically, IGF-I supports normal function, volume and hormone synthesis of the thyroid gland. Some of these effects are mediated through enhancement of sensitivity to the actions of TSH while others may be independent of pituitary function. IGF-I also participates in pathological conditions of the thyroid, including benign enlargement and tumorigenesis, such as those occurring in acromegaly. With regard to Graves\u2019 disease (GD) and the periocular process frequently associated with it, namely thyroid-associated ophthalmopathy (TAO), IGF-IR has been found overexpressed in orbital connective tissues, T and B cells in GD and TAO. Autoantibodies of the IgG class are generated in patients with GD that bind to IGF-IR and initiate the signaling from the TSHR\/IGF-IR physical and functional protein complex. Further, inhibition of IGF-IR with monoclonal antibody inhibitors can attenuate signaling from either TSHR or IGF-IR. Based on those findings, the development of teprotumumab, a \u03b2-arrestin biased agonist as a therapeutic has resulted in the first medication approved by the US FDA for the treatment of TAO. Teprotumumab is now in wide clinical use in North America.<\/jats:p>","DOI":"10.3389\/fendo.2021.653627","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T08:43:57Z","timestamp":1622796237000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Insulin-Like Growth Factor Pathway and the Thyroid"],"prefix":"10.3389","volume":"12","author":[{"given":"Terry J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"B1","article-title":"N. Paulescu, Discoverer of Insulin. 50th Anniversary of the Discovery of That Hormone","volume":"24","author":"Pavel","year":"1972","journal-title":"Med Int"},{"key":"B2","article-title":"Pancreatic Extracts in the Treatment of Diabetes Mellitus","volume":"12","author":"Banting","year":"1922","journal-title":"Can Med Assoc J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-19-7-743","article-title":"Sulfation Factor Activity of Sera From Patients With Pituitary Disorders","volume":"19","author":"Daughaday","year":"1959","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/235107a0","article-title":"Somatomedin: Proposed Designation for Sulphation Factor","volume":"235","author":"Daughaday","year":"1972","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-1-144","article-title":"Plasma Somatomedins, Endogenous Insulin Secretion, and Growth in Transient Neonatal Diabetes Mellitus","volume":"52","author":"Blethen","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346614","article-title":"Pathogenesis of Graves\u2019 Orbitopathy: A 2010 Update","volume":"33","author":"Smith","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010617-052509","article-title":"Challenges in Orphan Drug Development: Identification of Effective Therapy for Thyroid-Associated Ophthalmopathy","volume":"59","author":"Smith","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-Like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts From Patients With Graves\u2019 Disease is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/pr.109.002469","article-title":"Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases","volume":"62","author":"Smith","year":"2010","journal-title":"Pharmacol Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/0470869976.ch10","article-title":"Structural Biology of Insulin and IGF-1 Receptors","volume":"262","author":"De Meyts","year":"2004","journal-title":"Novartis Foundation Symposium"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000180557","article-title":"Somatomedin-C\/insulin-like Growth Factor-I as a Modulator of Growth During Childhood and Adolescence","volume":"24","author":"Furlanetto","year":"1986","journal-title":"Horm Res"},{"key":"B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-72204-7_1","article-title":"Insulin and IGF-I Receptor Structure and Binding Mechanism","volume-title":"Mechanisms of Insulin Action","author":"De Meyts","year":"2007"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"108307","DOI":"10.1016\/j.mrrev.2020.108307","article-title":"Nuclear Localization and Actions of the Insulin-Like Growth Factor 1 (IGF-1) System Components: Transcriptional Regulation and DNA Damage Response","volume":"784","author":"Poreba","year":"2020","journal-title":"Mutat Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.43.Suppl_S49","article-title":"Control of Insulin-Like Growth Factor (IGF) Action by Regulation of IGF-I Receptor Expression","author":"Roberts","year":"1996","journal-title":"Endocr J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415475111","article-title":"Insulin and Insulin-Like Growth Factor 1 Receptors are Required for Normal Expression of Imprinted Genes","volume":"111","author":"Boucher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/329301a0","article-title":"Insulin-Like Growth Factor II Receptor as a Multifunctional Binding Protein","volume":"329","author":"Morgan","year":"1987","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1050","article-title":"Mannose 6-Phosphate Receptors: New Twists in the Tale","volume":"4","author":"Ghosh","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/edrv-16-1-3","article-title":"Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.6.0382","article-title":"The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-100-24527","article-title":"Effect of Growth Hormone Upon Thyroid Secretion Rate in the Rat. Proceedings of the Society for Experimental Biology and Medicine","volume":"100","author":"Grosvenor","year":"1959","journal-title":"Soc Exp Biol Med (N Y NY)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/endo-65-2-158","article-title":"The Effect of Alterations in Thyroid Function on the Pituitary Growth Hormone Content and Acidophil Cytology","volume":"65","author":"Solomon","year":"1959","journal-title":"Endocrinology"},{"key":"B24","volume-title":"The Endocrine Organs in Health and Disease: With an Historical Review","author":"Rolleston","year":"1936"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/endo-121-2-749","article-title":"Interaction of Insulin-Like Growth Factor I With Porcine Thyroid Cells Cultured in Monolayer","volume":"121","author":"Saji","year":"1987","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1255","article-title":"Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors From Papillary Thyroid Cancer and Normal Thyroid","volume":"96","author":"Malaguarnera","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113764","article-title":"Demonstration of the Production and Physiological Role of Insulin-Like Growth Factor II in Rat Thyroid Follicular Cells in Culture","volume":"82","author":"Maciel","year":"1988","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)80125-4","article-title":"Expression of Insulin-Like Growth Factor-I and -II Genes in Rat Medullary Thyroid Carcinoma","volume":"215","author":"H\u00f6ppener","year":"1987","journal-title":"FEBS Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2.6.961","article-title":"Secretion and Binding of Insulin-Like Growth Factor-I by a Human Medullary-Thyroid Carcinoma Cell-Line","volume":"2","author":"Bethel","year":"1993","journal-title":"Int J Oncol"},{"key":"B30","article-title":"Expression of Mutant p21ras Induces Insulin-Like Growth Factor 1 Secretion in Thyroid Epithelial Cells","volume":"55","author":"Dawson","year":"1995","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320605","article-title":"Insulin-Like Growth Factor I Messenger Ribonucleic Acid Expression in Porcine Thyroid Follicles Is Regulated by Thyrotropin and Iodine","volume":"132","author":"Hofbauer","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320601","article-title":"Thyrotropin-Dependent Insulin-Like Growth Factor I mRNA Expression in Thyroid Cells","volume":"132","author":"Roger","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.02.035","article-title":"Differentiation of Murine Embryonic Stem Cells to Thyrocytes Requires Insulin and Insulin-Like Growth Factor-1","volume":"381","author":"Arufe","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02289","article-title":"Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes","volume":"104","author":"Kushchayeva","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/08977199009071497","article-title":"Interaction of TSH, Insulin and Insulin-Like Growth Factors in Regulating Thyroid Growth and Function","volume":"2","author":"Eggo","year":"1990","journal-title":"Growth Factors"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2007.22.5.883","article-title":"Microarray Analysis of Thyroid Stimulating Hormone, Insulin-Like Growth factor-1, and Insulin-Induced Gene Expression in FRTL-5 Thyroid Cells","volume":"22","author":"Lee","year":"2007","journal-title":"J Korean Med Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1038\/s41598-019-42198-7","article-title":"The Influence of the Lack of Insulin Receptor Substrate 2 (IRS2) on the Thyroid Gland","volume":"9","author":"Iglesias-Osma","year":"2019","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31779","article-title":"Thyrocyte-Specific Deletion of Insulin and IGF-1 Receptors Induces Papillary Thyroid Carcinoma-Like Lesions Through EGFR Pathway Activation","volume":"143","author":"Ock","year":"2018","journal-title":"Int J Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1375","article-title":"Immunoglobulin G From Patients With Graves\u2019 Disease Induces interleukin-16 and RANTES Expression in Cultured Human Thyrocytes: A Putative Mechanism for T-Cell Infiltration of the Thyroid in Autoimmune Disease","volume":"147","author":"Gianoukakis","year":"2006","journal-title":"Endocrinology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06486","article-title":"Transcriptional Regulation of Major Histocompatibility Complex Class I Gene by Insulin and IGF-I in FRTL-5 Thyroid Cells","volume":"189","author":"Giuliani","year":"2006","journal-title":"J Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0024","article-title":"Upstream Stimulatory Factor Regulates Constitutive Expression and Hormonal Suppression of the 90K (Mac-2BP) Protein","volume":"148","author":"Grassadonia","year":"2007","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1443","article-title":"Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3\u2019, 5\u2019-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1 in FRTL-5 Cells","volume":"149","author":"Fukushima","year":"2008","journal-title":"Endocrinology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1677\/JME-07-0020","article-title":"Phosphatidylinositol 3-Kinase\/Nuclear Factor-Kappa B Signaling Pathway is Involved in the Regulation of IGF-I on Fas-Associated Death Domain-Like interleukin-1-Converting Enzyme-Inhibitory Protein Expression in Cultured FRTL Thyroid Cells","volume":"38","author":"Ren","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80521-U","article-title":"Functional Regulation of GTP-binding Protein Coupled to Insulin-Like Growth Factor-I Receptor by Lithium During G1 Phase of the Rat Thyroid Cell Cycle","volume":"318","author":"Takada","year":"1993","journal-title":"FEBS Lett"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.3390\/ijms20133258","article-title":"Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment","volume":"20","author":"Manzella","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13409","article-title":"IGF-Iec Expression Is Associated With Advanced Differentiated Thyroid Cancer","volume":"39","author":"Karagiannis","year":"2019","journal-title":"Anticancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0174","article-title":"Diminished and Irregular Thyrotropin Secretion With Preserved Diurnal Rhythm in Patients With Active Acromegaly","volume":"94","author":"Roelfsema","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000247","article-title":"Thyroid Gland Changes in Patients With Acromegaly","volume":"64","author":"Natchev","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-9981-3","article-title":"Evaluation of Thyroid Diseases and Differentiated Thyroid Cancer in Acromegalic Patients","volume":"45","author":"Dogan","year":"2014","journal-title":"Endocrine"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0353","article-title":"Decrease In Acromegaly-Associated Thyroid Enlargement After Normalization Of Igf-1 Levels: A Prospective Observation and In Vitro Study","volume":"26","author":"Chen","year":"2020","journal-title":"Endocrine Practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1003632","article-title":"Increased Incidence of Euthyroid and Hyperthyroid Goiters Independently of Thyrotropin in Patients With Acromegaly","volume":"23","author":"W\u00fcster","year":"1991","journal-title":"Hormone Metab Res Hormon Und Stoffwechselforschung Hormones Metabol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.3.1179","article-title":"Growth Hormone Does Not Increase Thyroid Size in the Absence of Thyrotropin: A Study in Adults With Hypopituitarism","volume":"81","author":"Cheung","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-6-1227","article-title":"Supranormal Stimulation of Deoxyribonucleic Acid Synthesis in FRTL5 Cells by Serum From Patients With Untreated Acromegaly","volume":"66","author":"Misaki","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302012000500004","article-title":"Thyroid Nodules in Acromegaly","volume":"56","author":"Rogozinski","year":"2012","journal-title":"Arquivos Brasileiros Endocrinol E Metabol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jus.2010.09.008","article-title":"Thyroid Nodules in Acromegaly: The Role of Elastography","volume":"13","author":"Andrioli","year":"2010","journal-title":"J Ultrasound"},{"key":"B56","article-title":"The Occurrence of Thyroid Focal Lesions and a Need for Fine Needle Aspiration Biopsy in Patients With Acromegaly Due to an Increased Risk of Thyroid Cancer","volume":"30","author":"Ruchala","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0383-y","article-title":"Thyroid Cancer in Patients With Acromegaly: A Case-Control Study","volume":"16","author":"dos Santos","year":"2013","journal-title":"Pituitary"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid Cancer is the Most Common Cancer Associated With Acromegaly","volume":"13","author":"Gullu","year":"2010","journal-title":"Pituitary"},{"key":"B59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: Re-Thinking the Cancer Risk","volume":"9","author":"Loeper","year":"2008","journal-title":"Rev Endocrine Metab Disord"},{"key":"B60","article-title":"McCune-Albright Syndrome in Adulthood","author":"Chanson","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0345","article-title":"Three Endocrine Neoplasms: An Unusual Combination of Pheochromocytoma, Pituitary Adenoma, and Papillary Thyroid Carcinoma","volume":"22","author":"Sisson","year":"2012","journal-title":"Thyroid"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ11-0324","article-title":"Duodenal Adenocarcinoma With Neuroendocrine Features in a Patient With Acromegaly and Thyroid Papillary Adenocarcinoma: A Unique Combination of Endocrine Neoplasia","volume":"59","author":"Kato","year":"2012","journal-title":"Endocr J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-2-324","article-title":"Enhanced Peripheral Conversion of Thyroxine to Triiodothyronine During hGH Therapy in GH Deficient Children","volume":"45","author":"Sato","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01071.x","article-title":"Changes in Serum Thyroid Hormones Levels and Their Mechanisms During Long-Term Growth Hormone (GH) Replacement Therapy in GH Deficient Children","volume":"53","author":"Portes","year":"2000","journal-title":"Clin Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81190-4","article-title":"Growth and Thyroid Function in Children Treated With Growth Hormone","volume":"121","author":"Pirazzoli","year":"1992","journal-title":"J Pediatr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/endo-118-4-1483","article-title":"Insulin-Like Growth Factor-I Action on Hypothyroid Rat Pituitary Cells: Suppression of Triiodothyronine-Induced Growth Hormone Secretion and Messenger Ribonucleic Acid Levels","volume":"118","author":"Melmed","year":"1986","journal-title":"Endocrinology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0006-8993(87)90766-9","article-title":"Brain Neurons Develop in a Serum and Glial Free Environment: Effects of Transferrin, Insulin, Insulin-Like Growth Factor-I and Thyroid Hormone on Neuronal Survival, Growth and Differentiation","volume":"406","author":"Aizenman","year":"1987","journal-title":"Brain Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.2.604","article-title":"Enhancement of Somatomedin Titers of Normal and Hypopituitary Sera by Addition of L-triiodothyronone In Vitro At Physiological Concentrations","volume":"72","author":"Audhya","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5","article-title":"Thyroid Hormone-Mediated Growth and Differentiation of Growth Plate Chondrocytes Involves IGF-1 Modulation of Beta-Catenin Signaling","volume":"25","author":"Wang","year":"2010","journal-title":"J Bone Miner Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.37.23334","article-title":"Transcriptional Control of the Forkhead Thyroid Transcription Factor TTF-2 by Thyrotropin, Insulin, and Insulin-Like Growth Factor I","volume":"272","author":"Ortiz","year":"1997","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1042\/bj3030467","article-title":"Differential Regulation of the Expression of Fast-Type Sarcoplasmic-Reticulum Ca(2+)-ATPase by Thyroid Hormone and Insulin-Like Growth Factor-I in the L6 Muscle Cell Line","volume":"303","author":"Thelen","year":"1994","journal-title":"Biochem J"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02936.x","article-title":"Growth Hormone (GH) Treatment Reduces Peripheral Thyroid Hormone Action in Girls With Turner Syndrome","volume":"67","author":"Susperreguy","year":"2007","journal-title":"Clin Endocrinol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb26236.x","article-title":"Pituitary and Peripheral Insulin-Like Growth Factor-I Regulation by Thyroid Hormone","volume":"692","author":"Cacicedo","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.1.45","article-title":"Thyroid and Glucocorticoid Hormones Synergistically Control Growth Hormone mRNA in Cultured GH1 Cells","volume":"75","author":"Shapiro","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/endo-124-5-2277","article-title":"The Effect of Altered Thyroid Status on Pituitary Hormone Messenger Ribonucleic Acid Concentrations in the Rat","volume":"124","author":"Samuels","year":"1989","journal-title":"Endocrinology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1983.tb00007.x","article-title":"Growth Hormone Secretion and Plasma Somatomedin-C in Primary Hypothyroidism","volume":"19","author":"Chernausek","year":"1983","journal-title":"Clin Endocrinol"},{"key":"B77","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.157.8.3334","article-title":"Defective B Cell Development in Snell Dwarf (Dw\/Dw) Mice Can Be Corrected by Thyroxine Treatment","volume":"157","author":"Montecino-Rodriguez","year":"1996","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/endo.132.2.7678799","article-title":"Mechanisms of Thyroid Hormone Action on the Insulin-Like Growth Factor System: All Thyroid Hormone Effects Are Not Growth Hormone Mediated","volume":"132","author":"N\u00e4nt\u00f6-Salonen","year":"1993","journal-title":"Endocrinology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1159\/000180644","article-title":"Effect of Thyroid Hormone Therapy on Plasma Insulin-Like Growth Factor I Levels in Normal Subjects, Hypothyroid Patients and Endemic Cretins","volume":"25","author":"Cavaliere","year":"1987","journal-title":"Horm Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1180415","article-title":"Growth Factors and the Thyroid: Effects of Treatment for Hyper- and Hypothyroidism on Serum IGF-I and Urinary Epidermal Growth Factor Concentrations","volume":"118","author":"Westermark","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00352.x","article-title":"Thyroxine Treatment Increases Circulating Levels of Insulin-Like Growth Factor Binding protein-1: A Placebo-Controlled Study","volume":"38","author":"Angervo","year":"1993","journal-title":"Clin Endocrinol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/endo.131.3.1380443","article-title":"Insulin-Like Growth Factor Binding Protein Expression in the Hypothyroid Rat Is Age Dependent","volume":"131","author":"N\u00e4nt\u00f6-Salonen","year":"1992","journal-title":"Endocrinology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.76.5.7684392","article-title":"Thyroxine Withdrawal is Accompanied by Decreased Circulating Levels of Insulin-Like Growth Factor-Binding Protein-1 in Thyroidectomized Patients","volume":"76","author":"Angervo","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1210\/endo-119-3-1204","article-title":"Increase in the Number of Type II Insulin-Like Growth Factor Receptors During Propylthiouracil-Induced Hyperplasia in the Rat Thyroid","volume":"119","author":"Polychronakos","year":"1986","journal-title":"Endocrinology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1350115","article-title":"Effects of Tri-Iodothyronine and Insulin-Like Growth Factor-I (IGF-I) on Alkaline Phosphatase Activity, [3H]Thymidine Incorporation and IGF-I Receptor mRNA in Cultured Rat Epiphyseal Chondrocytes","volume":"135","author":"Ohlsson","year":"1992","journal-title":"J Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/endo-126-1-550","article-title":"Thyroid Hormone Regulates Rat Pituitary Insulin-Like Growth Factor-I Receptors","volume":"126","author":"Matsuo","year":"1990","journal-title":"Endocrinology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.3.5018","article-title":"Thyroid Hormone Controls the Expression of Insulin-Like Growth Factor I Receptor Gene At Different Levels in Lung and Heart of Developing and Adult Rats","volume":"138","author":"Moreno","year":"1997","journal-title":"Endocrinology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MED.0b013e32833c8942","article-title":"Molecular Regulation of Thyroid Gland Function","volume":"17","author":"Eggo","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M800211200","article-title":"G13-Dependent Activation of MAPK by Thyrotropin","volume":"283","author":"B\u00fcch","year":"2008","journal-title":"J Biol Chem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501129200","article-title":"{Beta}-Arrestin Is Crucial for Ubiquitination and Down-Regulation of the Insulin-Like Growth Factor-1 Receptor by Acting as Adaptor for the MDM2 E3 Ligase","volume":"280","author":"Girnita","year":"2005","journal-title":"J Biol Chem"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611526200","article-title":"Beta-Arrestin and Mdm2 Mediate IGF-1 Receptor-Stimulated ERK Activation and Cell Cycle Progression","volume":"282","author":"Girnita","year":"2007","journal-title":"J Biol Chem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216348110","article-title":"\u03b2-Arrestin-biased Agonism as the Central Mechanism of Action for Insulin-Like Growth Factor 1 Receptor-Targeting Antibodies in Ewing\u2019s Sarcoma","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2174\/156800909789271495","article-title":"Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy","volume":"9","author":"van der Veeken","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin-Like Growth Factor-I Stimulates the Growth of Rat Thyroid Cells in Culture and Synergizes the Stimulation of DNA Synthesis Induced by TSH and Graves\u2019-Igg","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)89525-8","article-title":"Thyrotropin and Insulin-Like Growth Factor I Regulation of Tyrosine Phosphorylation in FRTL-5 Cells. Interaction Between cAMP-Dependent and Growth Factor-Dependent Signal Transduction","volume":"266","author":"Takahashi","year":"1991","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113672","article-title":"Thyroid-Stimulating Hormone and Insulin-Like Growth Factor-1 Synergize to Elevate 1,2-Diacylglycerol in Rat Thyroid Cells. Stimulation of DNA Synthesis Via Interaction Between Lipid and Adenylyl Cyclase Signal Transduction Systems","volume":"82","author":"Brenner-Gati","year":"1988","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.3.8070365","article-title":"Divergent Patterns of Immediate Early Gene Expression in Response to Thyroid-Stimulating Hormone and Insulin-Like Growth Factor I in Wistar Rat Thyrocytes","volume":"135","author":"Tominaga","year":"1994","journal-title":"Endocrinology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an Association Between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves\u2019 Disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-231381","article-title":"IGF-1 Receptor Deficiency in Thyrocytes Impairs Thyroid Hormone Secretion and Completely Inhibits TSH-Stimulated Goiter","volume":"27","author":"Ock","year":"2013","journal-title":"FASEB J"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.12.8534","article-title":"Low TSH Requirement and Goiter in Transgenic Mice Overexpressing IGF-I and IGF-Ir Receptor in the Thyroid Gland","volume":"142","author":"Clement","year":"2001","journal-title":"Endocrinology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of Thyrotropin Receptor Antibody-Induced Signaling Cascades","volume":"150","author":"Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1159\/000063469","article-title":"Insulin and Insulin-Like Growth Factor I Receptors: Similarities and Differences in Signal Transduction","author":"Dupont","year":"2001","journal-title":"Horm Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0424","article-title":"Neutral Antibodies to the TSH Receptor Are Present in Graves\u2019 Disease and Regulate Selective Signaling Cascades","volume":"151","author":"Morshed","year":"2010","journal-title":"Endocrinology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2009.01.006","article-title":"The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling","volume":"38","author":"Latif","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.46.29400","article-title":"Thyrotropin Via Cyclic AMP Induces Insulin Receptor Expression and Insulin Co-stimulation of Growth and Amplifies Insulin and Insulin-Like Growth Factor Signaling Pathways in Dog Thyroid Epithelial Cells","volume":"271","author":"Burikhanov","year":"1996","journal-title":"J Biol Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1580","article-title":"Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes","volume":"99","author":"Chen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-3220","article-title":"A Phase I Study of Weekly R1507, a Human Monoclonal Antibody Insulin-Like Growth Factor-I Receptor Antagonist, in Patients With Advanced Solid Tumors","volume":"16","author":"Kurzrock","year":"2010","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.10000","article-title":"R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study","volume":"29","author":"Pappo","year":"2011","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.6799","article-title":"Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage non-Small-Cell Lung Cancer","volume":"29","author":"Ramalingam","year":"2011","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3892\/or.2011.1597","article-title":"A Humanized anti-IGF-1R Monoclonal Antibody (R1507) and\/or Metformin Enhance Gemcitabine-Induced Apoptosis in Pancreatic Cancer Cells","volume":"27","author":"Kawanami","year":"2012","journal-title":"Oncol Rep"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2372-x","article-title":"Phase 1b Study of Safety, Tolerability and Efficacy of R1507, a Monoclonal Antibody to IGF-1R in Combination With Multiple Standard Oncology Regimens in Patients With Advanced Solid Malignancies","volume":"73","author":"Mahadevan","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"151902","DOI":"10.1016\/j.imbio.2019.151902","article-title":"Insulin-Like Growth Factor-1 Enhances the Expression of Functional TSH Receptor in Orbital Fibroblasts From Thyroid-Associated Ophthalmopathy","volume":"225","author":"Paik","year":"2020","journal-title":"Immunobiology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 Disease","volume":"375","author":"Smith","year":"2016","journal-title":"New Engl J Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 Binding Sites in Thyroid Associated Ophthalmopathy","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs From Patients With Graves\u2019 Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.5.3281","article-title":"Aberrant Expression of the Insulin-Like Growth Factor-1 Receptor by T Cells From Patients With Graves\u2019 Disease may Carry Functional Consequences for Disease Pathogenesis","volume":"178","author":"Douglas","year":"2007","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5768","article-title":"B Cells From Patients With Graves\u2019 Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis","volume":"181","author":"Douglas","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2810","article-title":"Divergent Frequencies of IGF-I Receptor-Expressing Blood Lymphocytes in Monozygotic Twin Pairs Discordant for Graves\u2019 Disease: Evidence for a Phenotypic Signature Ascribable to Nongenetic Factors","volume":"94","author":"Douglas","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins From Patients With Graves\u2019 Disease Induce Hyaluronan Synthesis in Their Orbital Fibroblasts Through the Self-Antigen, Insulin-Like Growth Factor-I Receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.02.037","article-title":"Modulation of Hyaluronan Polymer Size Regulates Proliferation of Perimysial Fibroblasts in Thyroid Eye Disease","volume":"496","author":"Ma","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040862","article-title":"New Insights From IGF-IR Stimulating Activity Analyses: Pathological Considerations","volume":"9","author":"Janssen","year":"2020","journal-title":"Cells"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1210\/en.2019-00055","article-title":"Arrestin-\u03b2-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk","volume":"160","author":"Krieger","year":"2019","journal-title":"Endocrinology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for Thyroid-Associated Ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"New Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the Treatment of Active Thyroid Eye Disease","volume":"382","author":"Douglas","year":"2020","journal-title":"New Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12228","article-title":"The Adverse Events Profile of anti-IGF-1R Monoclonal Antibodies in Cancer Therapy","volume":"77","author":"Ma","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15704","article-title":"Update of IGF-1 Receptor Inhibitor (Ganitumab, Dalotuzumab, Cixutumumab, Teprotumumab and Figitumumab) Effects on Cancer Therapy","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of a Disease Specific Quality of Life Questionnaire for Patients With Graves\u2019 Ophthalmopathy: The GO-QOL","volume":"82","author":"Terwee","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01287-y","article-title":"Teprotumumab: First Approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"B129","doi-asserted-by":"publisher","first-page":"100744","DOI":"10.1016\/j.ajoc.2020.100744","article-title":"Early Experience With Teprotumumab for Chronic Thyroid Eye Disease","volume":"19","author":"Ozzello","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001831","article-title":"Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to Therapy","author":"Sears","year":"2020","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.5296","article-title":"Teprotumumab For Optic Neuropathy in Thyroid Eye Disease","author":"Slentz","year":"2020","journal-title":"Arch Ophthal (In Press)"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.09.003","article-title":"Resolution of Pretibial Myxedema With Teprotumumab in a Patient With Graves\u2019 Disease","author":"Aakaash Varma","year":"2020","journal-title":"JAAD Case Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.5.3564","article-title":"Synovial Fibroblasts From Patients With Rheumatoid Arthritis, Like Fibroblasts From Graves\u2019 Disease, Express High Levels of IL-16 When Treated With Igs Against Insulin-Like Growth Factor-1 Receptor","volume":"173","author":"Pritchard","year":"2004","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"110167","DOI":"10.1016\/j.mehy.2020.110167","article-title":"Is There a Role for Insulin-Like Growth Factor Inhibition in the Treatment of COVID-19-Related Adult Respiratory Distress Syndrome","volume":"144","author":"Winn","year":"2020","journal-title":"Med Hypotheses"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.653627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T14:03:50Z","timestamp":1699106630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.653627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":134,"alternative-id":["10.3389\/fendo.2021.653627"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.653627","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"article-number":"653627"}}